Epidemiology of Infections in ICUs: Where Are We?

  • M. Viviani
  • G. Berlot
  • A. Gullo


Patients admitted to intensive care units (ICUs) represent 8 to 15% of overall hospital population [1]. A frequent problem related to ICU stay is the relative high incidence of infections, rates of which are higher than 40% as reported in some prevalence studies [2, 3]. This percentage is 5–10 times higher when compared with the infections in patients admitted in the normal wards; furthermore, in some hospitals of United States, recurrence of infections in ICUs represents more than 20% of overall nosocomial infections [4].


Intensive Care Unit Nosocomial Infection Selective Decontamination Infect Control Hosp Hosp Infect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Weinstein RA (1991) Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med 91[Suppl 3B]: 179S–184SPubMedCrossRefGoogle Scholar
  2. 2.
    Vincent JL, Bihari DJ, Suter PM et al (1995) The prevalence of nosocomial infections in intensive care units in Europe. JAMA 274: 639–644PubMedCrossRefGoogle Scholar
  3. 3.
    de León-Rosales SP, Molinar-Ramos F, Domínguez-Cherit G et al (2000) Prevalence of infections in intensive care units in Mexico: a multicenter study. Crit Care Med 28: 1316–1321CrossRefGoogle Scholar
  4. 4.
    Craven DE, Kunches LM, Lichtemberg DA et al (1988) Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 148: 1161–1168PubMedCrossRefGoogle Scholar
  5. 5.
    NNIS System Report (1997) National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986–April 1997, issued May 1997. Am J Infect Control 25: 477–487CrossRefGoogle Scholar
  6. 6.
    Schaberg DR, Culver DH, Gaynes RP (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 91[Suppl 3B]: 72S–75SPubMedCrossRefGoogle Scholar
  7. 7.
    Bergogne-Bérézin E (1999) Current guidelines for the treatment and prevention of nosocomial infections. Drugs 58: 51–67PubMedCrossRefGoogle Scholar
  8. 8.
    D’Amico R, Pifferi S, Legnetti C et al (1998) Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. Br Med Journal 316: 1275–1285CrossRefGoogle Scholar
  9. 9.
    Trilla A (1994) Epidemiology of nosocomial infections in adult intensive care units. Int Care Med 20: S1–S4CrossRefGoogle Scholar
  10. 10.
    Legras A, Malvy D, Quinioux AI et al (1998) Nosocomial infections: prospective survey of incidence in five French intensive care units. Int Care Med 24: 1040–1046CrossRefGoogle Scholar
  11. 11.
    Gaynes RP, Culver DH, Emori TG et al (1991) The National Nosocomial Infections Surveillance System: plans for the 1990s and beyond. Am J Med 91[Suppl 3B]: 116S–120SPubMedCrossRefGoogle Scholar
  12. 12.
    Richards MJ, Edwards JR, Culver DH et al (1999) Nosocomial infections in medical intensive care units in the United States. Crit Care Med 27: 887–892PubMedCrossRefGoogle Scholar
  13. 13.
    Weber DJ, Raash R, Rutala WA (1999) Nosocomial infections in the ICU: the growing importance of antibiotic resistant pathogens. Chest 115: 34S–41SPubMedCrossRefGoogle Scholar
  14. 14.
    Wallace WC, Cinat M, Gornik WB et al (1999) Nosocomial infections in the surgical intensive care unit: a difference between trauma and surgical patients. Am Surg 65: 987–990PubMedGoogle Scholar
  15. 15.
    Garner JS, Jarvis WR, Emori TG et al (1988) CDC definitions for nosocomial infections. Am J Infect Control 16: 128–140PubMedCrossRefGoogle Scholar
  16. 16.
    Potgieter PD, Hammond JM (1992) Etiology and diagnosis of pneumonia requiring ICU admission. Chest 101: 199–203PubMedCrossRefGoogle Scholar
  17. 17.
    Mosconi P, Langer M, Cigada M et al (1991) Epidemiology and risk factors of pneumonia in critically ill patients. Eur J Epidemiol 7: 320–327PubMedCrossRefGoogle Scholar
  18. 18.
    Antonelli M, Moro ML, D’Errico RR et al (1996) Early and late onset bacteremia have a different risk factors in trauma patients. Int Care Med 22: 735–741CrossRefGoogle Scholar
  19. 19.
    Troullet JL, Chastre J, Vuagnat A et al (1998) Ventilator associated pneumonia caused by potentially drug resistant bacteria. Am J Respir Crit Care Med 157: 531–539Google Scholar
  20. 20.
    Van Saene HKF, Damjanovic V, Murray AE, de la Cal MA (1996) How to classify infections in intensive care units — the carrier state, a criterion whose time has come? J Hosp Infect 33: 1–12PubMedCrossRefGoogle Scholar
  21. 21.
    De la Cal MA, Cerdà E, Garcia-Hierro P (1998) Classification of micro-organisms according to their pathogenicity. In: van Saene HKF, Silvestri L, de la Cal MA (eds) Infection control in the Intensive Care Unit. Springer Verlag, pp 9-16Google Scholar
  22. 22.
    Silvestri L, Monti Bragadin C, Milanese M et al (1999) Are most ICU infections really nosocomial? A prospective observational cohort study in mechanically ventilated patients. J Hosp Infect 42: 125–133PubMedCrossRefGoogle Scholar
  23. 23.
    Nolla-Salas J, Sitges-Serra A, Leon-Gil C et al (1997) Candidaemia in non-neutropenic critically ill patients: analysis of prognosis factors and assessment of systemic antifungal therapy. Int Care Med 23: 23–30CrossRefGoogle Scholar
  24. 24.
    Petri MG, König J, Moeke HP et al (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Int Care Med 23: 317–325CrossRefGoogle Scholar
  25. 25.
    Pittet D, Monod M, Suter PM et al (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220: 751–758PubMedCrossRefGoogle Scholar
  26. 26.
    Vincent JL, Anaissie E, Bruining H et al (1998) Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Int Care Med 24: 206–216CrossRefGoogle Scholar
  27. 27.
    Flanagan PG, Barnes RA (1998) Fungal infection in the intensive care unit. J Hosp Infect 38: 163–177PubMedCrossRefGoogle Scholar
  28. 28.
    Johnson EW, Warnok DW (1995) Azole drug resistance in yeasts. J Antimicrob Chemother 36: 751–755PubMedCrossRefGoogle Scholar
  29. 29.
    Archibald L, Phillips L, Monnet D et al (1997) Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 24: 211–215PubMedCrossRefGoogle Scholar
  30. 30.
    Livermore DM (2000) Epidemiology of antibiotic resistance. Int Care Med 26: S14–S21CrossRefGoogle Scholar
  31. 31.
    Huang AH, Yan JJ, Wu JJ (2000) Rapid dissemination of Staphylococcus aureus with classic oxacillin resistance phenotype at a new university hospital. J Hosp Infect 44: 309–315PubMedCrossRefGoogle Scholar
  32. 32.
    van Saene, de la Cal MA, Petros AJ et al (1998) Management of antimicrobial resistance in the intensive care unit. In: van Saene HKF, Silvestri L, de la Cal MA (eds) Infection control in the Intensive Care Unit. Springer Verlag, pp 323-340Google Scholar
  33. 33.
    Brun-Buisson C, Legrand P, Rauss A et al (1989) Intestinal decontamination for control of multiresistant Gram-negative bacilli. Ann Intern Med 110: 873–881PubMedGoogle Scholar
  34. 34.
    Moellering RC (1998) The specter of glycopeptide resistance: current trends and future considerations. Am J Med 104: 3S–6SPubMedCrossRefGoogle Scholar
  35. 35.
    Goldman DA, Weinstein RA, Wenzel RP et al (1996) Strategies to prevent and control the emergence and spread of antimicrobial resistant microorganisms in hospitals. JAMA 275: 234–240CrossRefGoogle Scholar
  36. 36.
    Moro ML, Jepsen OB (1996) Infection control practices in intensive care units of 14 European countries. Int Care Med 22: 872–879CrossRefGoogle Scholar
  37. 37.
    Shlaes DM, Gerding DN, John JF et al (1997) Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 25: 584–599PubMedCrossRefGoogle Scholar
  38. 38.
    Souweine B, Traore O, Aublet-Cuvelier B et al (2000) Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J Hosp Infect 45: 107–116PubMedCrossRefGoogle Scholar
  39. 39.
    Kollef MH (1999) The prevention of ventilator associated pneumonia. N Engl J Med 340: 627–634PubMedCrossRefGoogle Scholar
  40. 40.
    Rahman M, Chattopadhyay B (2000) Handwashing: unanswered questions and compliance. J Hosp Infect 45: 249–250PubMedCrossRefGoogle Scholar
  41. 41.
    Sax H, Pittet D (2000) Disinfectants that do. Curr Opin Infect Dis 13: 395–399PubMedCrossRefGoogle Scholar
  42. 42.
    Flaherty JP, Weinstein RA (1996) Nosocomial infections caused by antibiotic-resistant organisms in the intensive care unit. Infect Control Hosp Epidemiol 17: 236–248PubMedCrossRefGoogle Scholar
  43. 43.
    O’Connel NH, Humphreys H (2000) Intensive care unit design and environmental factors in the acquisition of infection. J Hosp Infect 45: 255–262CrossRefGoogle Scholar
  44. 44.
    Jarvis WR. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: the complexity of the problemGoogle Scholar
  45. 45.
    Van Der Waaij D (1989) The ecology of human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Annu Rev Microbiol 43: 69–87PubMedCrossRefGoogle Scholar
  46. 46.
    Marshall JC, Christou NV, Meakins JL (1993) The gastrointestinal tract. The “undrained abscess” of multiple organ failure. Ann Surg 218: 111–119PubMedCrossRefGoogle Scholar
  47. 47.
    Marshall JC (1999) Gastrointestinal flora and its alterations in critical illness. Curr Opin Crit Care 51: 119–125CrossRefGoogle Scholar
  48. 48.
    Sganga G, Gangheri G, Castagneto M (1998) The gut: a central organ in the development of multiple organ system failure. In: van Saene HKF, Silvestri L, de la Cal MA (eds) Infection control in the Intensive Care Unit. Springer Verlag, pp 269-277Google Scholar
  49. 49.
    Feltis BA, Wells CL (2000) Does microbial translocation play a role in critical illness? Curr Opin Crit Care 6: 117–122CrossRefGoogle Scholar
  50. 50.
    O’Boyle CJ, MacFie J, Mitchell CJ et al (1998) Microbiology of bacterial translocation in humans. Gut 42: 29–35PubMedCrossRefGoogle Scholar
  51. 51.
    Edlund C, Hedberg M, Nord CE (2000) Ecological impact of beta-lactam treatment on normal human intestinal flora. In: Vincent JL (ed) 2000 Yearbook of Intensive Care and Emergency Medicine. Springer Verlag, pp 111-122Google Scholar
  52. 52.
    Nathens AB, Marshall JC (1999) Selective decontamination of the digestive tract in surgical patients: a systematic review of evidence. Arch Surg 134: 170–176PubMedCrossRefGoogle Scholar
  53. 53.
    Baxby D, van Saene HKF, Stoutenbeek CP, Zandstra DF (1996) Selective decontamination of the digestive tract: 13 years on, what it is and what it is not. Int Care Med 22: 699–706CrossRefGoogle Scholar
  54. 54.
    Fowler RA, Cheung AM, Marshall JC (1999) Selective decontamination of the digestive tract in the critically ill patients. Int Care Med 25: 1323–1326CrossRefGoogle Scholar
  55. 55.
    Rocha RA, Martin MJ, Pita S et al (1992) Prevention of nosocomial infections in critically ill patients by selective decontamination of the digestive tract. A randomised double blind placebo-controlled study. Int Care Med 18: 398–404CrossRefGoogle Scholar
  56. 56.
    Garcia MS, Galoche JAC, Diaz JL et al (1998) Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients: a randomized, double-blind, placebo-controlled, multicenter trial. Am J Respir Crit Care Med 158: 908–916Google Scholar
  57. 57.
    Coello R, Glynn JR, Gaspar C et al (1997) Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect 37: 39–46PubMedCrossRefGoogle Scholar
  58. 58.
    Dacre J, Emmerson AM, Jenner EA (1986) Gentamicin-methicillin-resistant Staphylococcus aureus: epidemiology and containment of an outbreak. J Hosp Infect 7: 130–136PubMedCrossRefGoogle Scholar
  59. 59.
    Wenzel RP, Nettleman MD, Jones RN, Pfaller MA (1991) Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med 91[Suppl 3B]: 221S–227SPubMedCrossRefGoogle Scholar
  60. 60.
    Cookson BD (1990) Mupirocin resistance in Staphylococci. J Antimicrob Chemother 25: 497–503PubMedCrossRefGoogle Scholar
  61. 61.
    Miller MA, Dascal A, Portnoy J, Mendelson J (1996) Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 17: 811–813PubMedCrossRefGoogle Scholar
  62. 62.
    Pugin J, Auckenthaler R, Lew DP, Suter PM (1991) Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. JAMA 265: 2704–2710PubMedCrossRefGoogle Scholar
  63. 63.
    Hill RLR, Casewell MW (2000) The in-vitro activity of povidone-iodine cream against Staphylococcus aureus and its bioavailability in nasal secretions. J Hosp Infect 45: 198–205PubMedCrossRefGoogle Scholar
  64. 64.
    Viviani M, Berlot G, Dezzoni R et al (2000) The impact of topical vancomycin on MRSA gut carriage and infections in ICU patients. Int Care Med 26: S292CrossRefGoogle Scholar
  65. 65.
    Silvestri L, Mannucci F, van Saene HKF (2000) Selective decontamination of the digestive tract: a life saver. J Hosp Infect 45: 185–190PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 2001

Authors and Affiliations

  • M. Viviani
  • G. Berlot
  • A. Gullo

There are no affiliations available

Personalised recommendations